Trial Profile
A phase II trial of PTX 9908 in patients with unresectable hepatocellular carcinoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2013
Price :
$35
*
At a glance
- Drugs PTX 9908 (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 11 Sep 2013 New trial record